Source: Annual Congress 2011 - Challenges in tuberculosis control
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Tashpulatova (Tashkent, Uzbekistan). Forecasting the risk of medicinal complications from the chemical therapy in patients with multi-resistant pulmonary tuberculosis. Eur Respir J 2011; 38: Suppl. 55, 4370

Member's Comments

No comment yet.

Related content which might interest you: Risk of tuberculosis in pediatric patients treated with biological agents Source: Virtual Congress 2020 – Aspects of acute and chronic airway infections in children Year: 2020 The etiology and antimicrobial drugs resistance of microorganisms in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: Suppl. 50, 2s Year: 2006 Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases Year: 2020 Monitoring of drug resistance of TB mycobacteria in new pulmonary TB patients Source: Annual Congress 2010 - Tuberculosis drug resistance Year: 2010 Risk factors for infections with potentially resistant pathogens in patients in a pneumological intensive-care-unit Source: Eur Respir J 2002; 20: Suppl. 38, 476s Year: 2002 Relapse and failure pulmonary tuberculosis patients have the chance of cure with major antituberculosis drugs Source: Eur Respir J 2007; 30: Suppl. 51, 657s Year: 2007 Previous antibacterial therapy and drug-resistance among pathogens in ICU patients with nosocomial pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 405s Year: 2001 Monitoring of antituberculous drugs adverse events during the treatment of multidrug-resistant pulmonary tuberculosis Source: Annual Congress 2011 - Treatment of tuberculosis and adverse drug reactions Year: 2011 Non-pharmacological factors for the emergence of drug resistance in patients of pulmonary tuberculosis: An Indian overview Source: Annual Congress 2012 - MDR- and XDR-TB: clinical and public health experiences Year: 2012 Efficiency of standard chemotherapy of patients with pulmonary TB with relapses and treatment failure at drug resistance of M. tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 339s Year: 2001 Sudden deaths amongst inpatients with active pulmonary tuberculosis following commencement of antimicrobial therapy Source: Eur Respir J 2003; 22: Suppl. 45, 158s Year: 2003 Cardiovascular disease risk in patients with nontuberculous mycobacteria disease treated with macrolide Source: International Congress 2017 – Clinical update on bronchiectasis and nontuberculous mycobacteria (NTM) infections Year: 2017 Application of therapeutic pneumoperitoneum for multi-drug resistant cavitary TB in HIV – infected patients Source: Eur Respir J 2004; 24: Suppl. 48, 650s Year: 2004 Macrolide therapy for pneumonia: balancing benefits with cardiovascular risks Source: International Congress 2014 – ERS/JAMA lunchtime session: 2014 highlights Year: 2014 Whether there are pharmacoeconomic and other advantages of using procalcitonin-guide antibacterial treatment in patients with severe community-acquired pneumonia in developing countries? Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015 Perspectives on antibiotic treatment of NTM pulmonary disease Source: Eur Respir Monogr 2017; 75: 245-252 Year: 2017 Evaluation of tuberculosis risk in patients submitted to chronic immunosuppressive therapy for osteoarticular immune disease Source: Eur Respir J 2006; 28: Suppl. 50, 131s Year: 2006 Two major problems in TB patients today: MDR and the abandoned therapy Source: Annual Congress 2011 - Challenges in tuberculosis control Year: 2011 Pharmacoepidemiology of antibiotics using for treatment severe pulmonary infections in a clinical city hospital Source: Eur Respir J 2005; 26: Suppl. 49, 640s Year: 2005 Predictors of treatment failure among pulmonary tuberculosis patients in Pakistan Source: International Congress 2019 – Tuberculosis: from diagnosis to complications Year: 2019